Ying Wang

Dr. Ying Wang received her PhD in Faculty of Pharmaceutical Sciences at the University of British Columbia and continued her career development as a postdoctoral fellow at the Centre for Heart Lung Innovation and Stanford University. She was awarded the Elaine W. Raines Early Career Investigator Award by the American Heart Association in 2016 and Junior Investigator Award by the Leducq Foundation PlaqOmics Consortium in 2019-2021 for her work that changed the way people look at atherosclerosis disease.

Her research is focused on studying cell-cell and cell-microenvironment interactions to determine why diseased cells accumulate in atherosclerotic lesions and how we can remove them. ‘Functional omics on a tissue slide’ is the current theme of Dr. Wang’s research. With a combination of biobank-associated studies, spatial biology technology, and molecular biology, researchers in the Wang lab aim to develop new therapeutic and diagnostic tools for better treatment and prediction of atherosclerotic disease.

Ying is also the director of the Bruce McManus Cardiovascular Biobank. She works closely with researchers from multidisciplinary backgrounds to increase the impact of biobank research.

For an up-to-date list of publications by Ying, please visit the Wang Lab website or her NCBI bibliography.